HPV Vaccination - A Missed Opportunity, UK
The Royal Society of Health (RSH) welcomes the decision to introduce a national HPV vaccination programme, but with reservations. Responding to the decision taken by the Department of Health last week to use ‘Cervarix’, one of two HPV vaccines on the market, Professor Richard Parish, RSH Chief Executive said: “The health benefits of vaccination will be considerable, but they could have been much greater.
